Standard Operating Procedure for Registration Document Gap Assessment

Department	Regulatory Affairs
SOP No.	RA/2026/652
Supersedes	NA
Page No.	1 of X
Issue Date	10/04/2026
Effective Date	10/04/2026
Review Date	10/04/2028

Purpose

This Standard Operating Procedure (SOP) defines the systematic process for conducting a gap assessment of registration documents to ensure completeness, compliance, and readiness for regulatory submissions. The objective is to identify missing, incomplete, or outdated information within registration dossiers, ensuring alignment with applicable regulatory requirements and facilitating timely product registration and market entry.

Scope

This SOP applies to all regulatory affairs personnel involved in the preparation, review, and submission of product registration dossiers across all dosage forms and therapeutic categories within the organization. It covers the evaluation of documents including but not limited to product dossiers, administrative forms, technical summaries, certificates, and supporting quality data. This SOP excludes activities related to pharmacovigilance, clinical trials, and post-approval changes which are covered under separate procedures.

Responsibilities

• Regulatory Affairs Executive – Execute the document gap assessment as per defined criteria.
• Regulatory Affairs Reviewer – Review the gap assessment findings and recommend necessary actions.
• Regulatory Affairs Supervisor/Manager – Supervise the assessment process and ensure timely completion.
• Quality Assurance (QA) – Verify compliance with regulatory requirements and audit readiness.
• Documentation Control – Maintain version control and archive final assessment records.

Accountability

The Regulatory Affairs Manager is accountable for the overall implementation, compliance, and periodic review of this SOP. They will ensure that escalations of non-conformities are addressed promptly and that the assessment process remains effective, compliant, and aligned with regulatory updates.

Procedure

The Registration Document Gap Assessment shall be carried out in the following stages:

1. Preparation: The Regulatory Affairs Executive shall obtain the complete dossier set intended for submission, including all associated regulatory forms, certificates, and technical documents. Verify that the latest document versions are available as per documentation control databases.

2. Review of Applicable Regulatory Requirements: Identify the target market(s) and retrieve the latest regulatory guidelines, checklists, and requirements applicable to that jurisdiction. Confirm relevant formats and templates that registration documents must adhere to.

3. Document Verification: Perform a systematic comparison of the dossier content against regulatory checklists and submission requirements. Key elements to verify include completeness of data, presence of valid certificates (e.g., GMP, COA), accuracy of administrative information, adherence to format and structure, and consistency of technical data.

4. Identification of Gaps and Non-Compliance: Document any missing, incomplete, inconsistent, or non-compliant items found during verification. Categorize gaps based on criticality and potential impact on submission acceptance or regulatory approval timelines.

5. Communication and Follow-up: Prepare a detailed gap assessment report summarizing findings, including reference to specific document sections and regulatory clauses. Share the report with relevant stakeholders such as dossier preparers, quality assurance, and management for corrective action.

6. Verification of Corrective Actions: Upon receipt of revised or additional documents addressing the gaps, conduct a re-assessment to confirm closure of identified issues. Ensure all corrective data are documented and version controlled.

7. Approval and Record Retention: The final validated gap assessment report shall be reviewed and approved by the Regulatory Affairs Manager. All records, including the completed assessment, corrective actions, communications, and approvals, shall be maintained according to documentation retention policies.

8. Continuous Improvement: Periodically review and update the gap assessment checklist and procedure to incorporate changes from regulatory updates, audit findings, and internal feedback to enhance compliance and efficiency.

Throughout the process, ensure compliance with GMP, GxP documentation standards, and internal quality management system requirements. Any deviations or unexpected findings must be formally documented, investigated, and managed as per respective SOPs.

Abbreviations

• GMP – Good Manufacturing Practices
• QA – Quality Assurance
• SOP – Standard Operating Procedure
• COA – Certificate of Analysis
• GxP – Good Practices (collective term for Good Laboratory, Clinical, Manufacturing Practices)
• Dossier – Compilation of documents submitted for regulatory approval

Documents

The following documents are required to perform and document the registration document gap assessment process:

1. Registration Document Gap Assessment Checklist (Annexure-1)
2. Gap Assessment Report Template (Annexure-2)
3. Corrective Action Log for Registration Documents (Annexure-3)

References

• ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• European Medicines Agency (EMA) Guideline on dossier requirements
• US FDA Guidance for Industry: Content and Format of Abbreviated New Drug Applications
• Internal Quality Management System Documentation Control SOP
• Relevant country-specific regulatory authority submission guidelines

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Registration Document Gap Assessment Checklist

Purpose: To systematically verify completeness and compliance of registration dossier documents against regulatory requirements.

Document Item	Status (Present/Absent/Incomplete)	Comments
Product Dossier Cover Page	Present
Administrative Information Form	Present
Quality Technical Summary	Incomplete	Section 3.2 missing validation data
Certificate of Analysis (COA)	Present
GMP Certificate	Present	Valid until 15/08/2027
Stability Data	Absent	Stability report not included
Labeling and Packaging Information	Present
Previous Regulatory Approvals or Correspondence	Present

Annexure-2: Gap Assessment Report Template

Purpose: To document findings from the registration document gap assessment, including identified gaps, corrective actions, and status.

Report ID	GAP-RA-2026-001
Date of Assessment	10/04/2026
Assessor	Regulatory Affairs Executive
Product Name	Product XYZ
Market/Country	EU Member States
Summary of Findings	Missing stability data impacting dossier completeness Incomplete validation data in Quality Technical Summary
Recommended Actions	Obtain and include stability report Complete validation section with required data
Status	Open
Reviewed By
Approved By

Annexure-3: Corrective Action Log for Registration Documents

Purpose: To track and document corrective actions implemented to close identified gaps in registration documentation.

Action ID	Description	Responsibility	Target Date	Status	Verification Date	Verified By
CA-001	Inclusion of full stability report	Regulatory Affairs Executive	25/04/2026	Pending
CA-002	Completion of validation data in QTS	Quality Assurance	30/04/2026	In Progress

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
10/04/2026	1.0	Initial issue	New SOP creation